| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-59403-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2648-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61887-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61693-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61769-0.025ml | |||
![Western Blot: EIG121 Antibody [NBP2-81949] - Analysis of EIG121 in MCF7 cell lysate with EIG121 antibody at 1 ug/ml in the (A) absence and (B) presence of blocking peptide.](http://images.novusbio.com/fullsize/EIG121-Antibody-Western-Blot-NBP2-81949-img0001.jpg "Western Blot: EIG121 Antibody [NBP2-81949] - Analysis of EIG121 in MCF7 cell lysate with EIG121 antibody at 1 ug/ml in the (A) absence and (B) presence of blocking peptide.")
![Immunocytochemistry/ Immunofluorescence: EIG121 Antibody - BSA Free [NBP2-81949] - Immunocytochemistry of EIG121 in MCF7 cells with EIG121 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-81949_rabbit-polyclonal-eig121-antibody-271120242014191.jpg)
![Immunocytochemistry/ Immunofluorescence: EIG121 Antibody - BSA Free [NBP2-81949] - Immunofluorescence of EIG121 in MCF7 cells with EIG121 antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp2-81949_rabbit-polyclonal-eig121-antibody-271120241943223.jpg)
![Western Blot: eIF5A Antibody (4D1) [NBP2-59403] - Lane 1: Jurkat cell lysates, Lane 2: 293T cell lysates, Lane 3: HeLa cell lysates, Lane 4: MCF7 cell lysates, Lane 5: NIH-3T3 cell lysates](http://images.novusbio.com/fullsize/eIF5A-Antibody-4D1-Western-Blot-NBP2-59403-img0001.jpg "Western Blot: eIF5A Antibody (4D1) [NBP2-59403] - Lane 1: Jurkat cell lysates, Lane 2: 293T cell lysates, Lane 3: HeLa cell lysates, Lane 4: MCF7 cell lysates, Lane 5: NIH-3T3 cell lysates")
![Immunocytochemistry/Immunofluorescence: eIF5A Antibody (4D1) [NBP2-59403] - Analysis of EIF5A in Balb/3T3 cells line, stained with DAPI (Blue) for nucleus staining and monoclonal anti-human EIF5A antibody (1:100) with goat anti-mouse IgG-Alexa fluor 488 conjugate (Green)](http://images.novusbio.com/fullsize/eIF5A-Antibody-4D1-Immunocytochemistry-Immunofluorescence-NBP2-59403-img0002.jpg)
![Flow Cytometry: eIF5A Antibody (4D1) [NBP2-59403] - Analysis of EIF5A in Balb/3T3 cell line, staining at 2-5ug for 1x106cells (red line). The secondary antibody used goat anti-mouse IgG Alexa fluor 488 conjugate. Isotype control antibody was mouse IgG (black line)](http://images.novusbio.com/fullsize/eIF5A-Antibody-4D1-Flow-Cytometry-NBP2-59403-img0003.jpg)
![Western Blot: WDR18 Antibody [NBP2-81877] - Western blot analysis of WDR18 in rat lung tissue lysate with WDR18 antibody at (A) 0.5 and (B) 1 ug/mL.](http://images.novusbio.com/fullsize/WDR18-Antibody-Western-Blot-NBP2-81877-img0001.jpg "Western Blot: WDR18 Antibody [NBP2-81877] - Western blot analysis of WDR18 in rat lung tissue lysate with WDR18 antibody at (A) 0.5 and (B) 1 ug/mL.")
![Immunohistochemistry: WDR18 Antibody [NBP2-81877] - Immunohistochemistry of WDR18 in human lung tissue with WDR18 antibody at 2.5 ug/mL.](http://images.novusbio.com/fullsize/WDR18-Antibody-Immunohistochemistry-NBP2-81877-img0002.jpg)
![Western Blot: SPACA9 Antibody [NBP2-82011] - Analysis of SPACA9 in HeLa cell lysate with SPACA9 antibody at (A) 1 and (B) 2 ug/ml.](http://images.novusbio.com/fullsize/SPACA9-Antibody-Western-Blot-NBP2-82011-img0001.jpg "Western Blot: SPACA9 Antibody [NBP2-82011] - Analysis of SPACA9 in HeLa cell lysate with SPACA9 antibody at (A) 1 and (B) 2 ug/ml.")
![Immunocytochemistry/ Immunofluorescence: SPACA9 Antibody - BSA Free [NBP2-82011] - Immunofluorescence of SPACA9 in HeLa cells with SPACA9 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-82011_rabbit-polyclonal-spaca9-antibody-271120241956215.jpg)
![Immunocytochemistry/ Immunofluorescence: SPACA9 Antibody - BSA Free [NBP2-82011] - Immunofluorescence of SPACA9 in HeLa cells with SPACA9 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-82011_rabbit-polyclonal-spaca9-antibody-2711202419541580.jpg)
![Western Blot: t-Plasminogen Activator/tPA Antibody (10W4L1) [NBP3-16356] - Western blot analysis of extracts of various cell lines, using tPA/t-Plasminogen Activator/tPA Rabbit mAb (NBP3-16356) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-10W4L1-Western-Blot-NBP3-16356-img0002.jpg "Western Blot: t-Plasminogen Activator/tPA Antibody (10W4L1) [NBP3-16356] - Western blot analysis of extracts of various cell lines, using tPA/t-Plasminogen Activator/tPA Rabbit mAb (NBP3-16356) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.")
![Immunocytochemistry/Immunofluorescence: t-Plasminogen Activator/tPA Antibody (10W4L1) [NBP3-16356] - NIH/3T3 cells using tPA/PLAT Rabbit mAb (at dilution of 1:100) (Red). The cells were counterstained with alpha -Tubulin Mouse mAb (dilution 1:400) (Green). DAPI was used for nuclear staining (blue). Objective: 100x.](http://images.novusbio.com/fullsize/nbp3-16356_rabbit-t-plasminogen-activator-tpa-mab-10w4l1-immunocytochemistry-immunofluorescence-5102023103255..jpg)
![Western Blot: WIPI1 Antibody [NBP2-82048] - Analysis of WIPI1 in rat colon tissue lysate with WIPI1 antibody at (A) 1 and (B) 2 ug/ml.](http://images.novusbio.com/fullsize/WIPI1-Antibody-Western-Blot-NBP2-82048-img0001.jpg "Western Blot: WIPI1 Antibody [NBP2-82048] - Analysis of WIPI1 in rat colon tissue lysate with WIPI1 antibody at (A) 1 and (B) 2 ug/ml.")
![Immunocytochemistry/ Immunofluorescence: WIPI1 Antibody - BSA Free [NBP2-82048] - Immunofluorescence of WIPI1 in human colon tissue with WIPI1 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp2-82048_rabbit-polyclonal-wipi1-antibody-27112024203263.jpg)
![Western Blot: Chymase/CMA1/Mast Cell Chymase Antibody (2O4P8) [NBP3-15389] - Analysis of extracts of various cell lines, using Chymase/CMA1/Mast Cell Chymase (CMA1) Rabbit mAb (NBP3-15389) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/Chymase-CMA1-Mast-Cell-Chymase-Antibody-2O4P8-Western-Blot-NBP3-15389-img0002.jpg "Western Blot: Chymase/CMA1/Mast Cell Chymase Antibody (2O4P8) [NBP3-15389] - Analysis of extracts of various cell lines, using Chymase/CMA1/Mast Cell Chymase (CMA1) Rabbit mAb (NBP3-15389) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.")
![Immunohistochemistry-Paraffin: Chymase/CMA1/Mast Cell Chymase Antibody (2O4P8) [NBP3-15389] - Human appendix using Chymase/CMA1/Mast Cell Chymase (CMA1) Rabbit mAb (NBP3-15389) at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM PBS buffer pH 7.2 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/Chymase-CMA1-Mast-Cell-Chymase-Antibody-2O4P8-Immunohistochemistry-Paraffin-NBP3-15389-img0001.jpg)
![Western Blot: Apc1 Antibody (7G9C7) [NBP2-61887] - Analysis using ANAPC1 mAb against human ANAPC1 (AA: 12-155) recombinant protein. (Expected MW is 41.9 kDa)](http://images.novusbio.com/fullsize/Apc1-Antibody-7G9C7-Western-Blot-NBP2-61887-img0003.jpg "Western Blot: Apc1 Antibody (7G9C7) [NBP2-61887] - Analysis using ANAPC1 mAb against human ANAPC1 (AA: 12-155) recombinant protein. (Expected MW is 41.9 kDa)")
![Flow Cytometry: Apc1 Antibody (7G9C7) [NBP2-61887] - Analysis of MCF-7 cells using ANAPC1 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/Apc1-Antibody-7G9C7-Flow-Cytometry-NBP2-61887-img0002.jpg)
![Western Blot: Apc1 Antibody (7G9C7) [NBP2-61887] - Analysis using ANAPC1 mAb against HEK293 (1) and ANAPC1 (AA: 12-155)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Apc1-Antibody-7G9C7-Western-Blot-NBP2-61887-img0004.jpg)
![ELISA: Apc1 Antibody (7G9C7) [NBP2-61887] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/Apc1-Antibody-7G9C7-ELISA-NBP2-61887-img0001.jpg)
![Western Blot: SRA1 Antibody (1D4H8) [NBP1-51531] - Analysis using SRA mouse mAb against truncated SRA recombinant protein (1), human ovary cancer tissue lysate (2) and A431 cell lysate (3).](http://images.novusbio.com/fullsize/SRA1-Antibody-1D4H8-Western-Blot-NBP1-51531-img0001.jpg "Western Blot: SRA1 Antibody (1D4H8) [NBP1-51531] - Analysis using SRA mouse mAb against truncated SRA recombinant protein (1), human ovary cancer tissue lysate (2) and A431 cell lysate (3).")
![Immunohistochemistry-Paraffin: SRA1 Antibody (1D4H8) [NBP1-51531] - Analysis of human skin carcinoma (left) and breast carcinoma (right), showing cytoplasmic and membrane localization using SRA mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/SRA1-Antibody-1D4H8-Immunohistochemistry-Paraffin-NBP1-51531-img0002.jpg)
![Western Blot: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis using CD16 mAb against human CD16 (AA: extra 17-208) recombinant protein. (Expected MW is 47.8 kDa)](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-Western-Blot-NBP2-61693-img0003.jpg "Western Blot: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis using CD16 mAb against human CD16 (AA: extra 17-208) recombinant protein. (Expected MW is 47.8 kDa)")
![Flow Cytometry: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis of Ramos cells using CD16 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-Flow-Cytometry-NBP2-61693-img0002.jpg)
![Western Blot: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis using CD16 mAb against HEK293 (1) and CD16 (AA: extra 17-208)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-Western-Blot-NBP2-61693-img0004.jpg)
![ELISA: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-ELISA-NBP2-61693-img0001.jpg)
![Western Blot: ERR alpha/NR3B1 Antibody (1A6E11) [NBP2-61769] - Analysis using ESRRA mAb against human ESRRA (AA: 198-376) recombinant protein. (Expected MW is 45.3 kDa)](http://images.novusbio.com/fullsize/ERR-alpha-NR3B1-Antibody-1A6E11-Western-Blot-NBP2-61769-img0003.jpg "Western Blot: ERR alpha/NR3B1 Antibody (1A6E11) [NBP2-61769] - Analysis using ESRRA mAb against human ESRRA (AA: 198-376) recombinant protein. (Expected MW is 45.3 kDa)")
![Flow Cytometry: ERR alpha/NR3B1 Antibody (1A6E11) [NBP2-61769] - Analysis of Hela cells using ESRRA mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/ERR-alpha-NR3B1-Antibody-1A6E11-Flow-Cytometry-NBP2-61769-img0002.jpg)
![Western Blot: ERR alpha/NR3B1 Antibody (1A6E11) [NBP2-61769] - Analysis using ESRRA mAb against HEK293 (1) and ESRRA (AA: 198-376)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/ERR-alpha-NR3B1-Antibody-1A6E11-Western-Blot-NBP2-61769-img0004.jpg)
![ELISA: ERR alpha/NR3B1 Antibody (1A6E11) [NBP2-61769] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/ERR-alpha-NR3B1-Antibody-1A6E11-ELISA-NBP2-61769-img0001.jpg)